Literature DB >> 1426026

Differential effects of cytochrome P-450 induction on ligand binding to sigma receptors.

A S Basile1, I A Paul, B de Costa.   

Abstract

The identity of the sigma receptor as a form of cytochrome P-450 was investigated in rats treated with 3-methylcholanthrene or phenobarbital. The density of [3H]N,N'-di(o-tolyl)guanidine (DTG) binding to sigma 2 receptors in hepatic subcellular fractions increased following both treatments, while [3H](+)-pentazocine binding to sigma 1 receptors was unchanged. Furthermore, proadifen and piperonyl butoxide inhibited [3H](+)-pentazocine and [3H]DTG binding with low potency. The low affinity of cytochrome P-450 inhibitors for sigma receptors, the similar degree of enhancement of [3H]DTG binding by agents with disparate cytochrome P-450 induction profiles and the lack of change in [3H](+)-pentazocine binding are inconsistent with the identity of the sigma receptor as a cytochrome P-450.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1426026     DOI: 10.1016/0922-4106(92)90148-o

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  3 in total

1.  Small molecule modulator of sigma 2 receptor is neuroprotective and reduces cognitive deficits and neuroinflammation in experimental models of Alzheimer's disease.

Authors:  Bitna Yi; James J Sahn; Pooneh Memar Ardestani; Andrew K Evans; Luisa L Scott; Jessica Z Chan; Sangeetha Iyer; Ashley Crisp; Gabriella Zuniga; Jonathan T Pierce; Stephen F Martin; Mehrdad Shamloo
Journal:  J Neurochem       Date:  2017-02       Impact factor: 5.372

Review 2.  Current hypotheses on sigma receptors and their physiological role: possible implications in psychiatry.

Authors:  G Debonnel
Journal:  J Psychiatry Neurosci       Date:  1993-07       Impact factor: 6.186

3.  Trends in Sigma-1 Receptor Research: A 25-Year Bibliometric Analysis.

Authors:  Luz Romero; Enrique Portillo-Salido
Journal:  Front Pharmacol       Date:  2019-05-24       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.